DaBomb Protein Biotech Corp. (6578.TWO)
- Previous Close
17.35 - Open
17.25 - Bid 17.10 x --
- Ask 17.20 x --
- Day's Range
17.10 - 17.30 - 52 Week Range
15.20 - 33.90 - Volume
70,108 - Avg. Volume
131,563 - Market Cap (intraday)
1.163B - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
100.59 - EPS (TTM)
0.17 - Earnings Date --
- Forward Dividend & Yield 0.51 (2.98%)
- Ex-Dividend Date Jul 30, 2024
- 1y Target Est
--
DaBomb Protein Biotech Corp. engages in the development of antibiotics alternatives in animal health industry. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023. DaBomb Protein Biotech Corp. was founded in 2001 and is based in Tainan, Taiwan.
www.dabombprotein.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 6578.TWO
View MorePerformance Overview: 6578.TWO
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6578.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6578.TWO
View MoreValuation Measures
Market Cap
1.16B
Enterprise Value
1.03B
Trailing P/E
100.59
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.46
Price/Book (mrq)
1.07
Enterprise Value/Revenue
3.04
Enterprise Value/EBITDA
29.34
Financial Highlights
Profitability and Income Statement
Profit Margin
3.44%
Return on Assets (ttm)
-0.08%
Return on Equity (ttm)
1.14%
Revenue (ttm)
337.82M
Net Income Avi to Common (ttm)
11.64M
Diluted EPS (ttm)
0.17
Balance Sheet and Cash Flow
Total Cash (mrq)
253.59M
Total Debt/Equity (mrq)
15.43%
Levered Free Cash Flow (ttm)
8.9M